1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull WHO. 2004;82(11):844-51.
2. Aström S, Stenlund H, Lindén C. Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up. Acta Ophthalmologica Scandinavica. 2007;85(8):832-7.
3. Ritch R, Schlotzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45(4):265-315.
4. Dewundara S, Pasquale LR. Exfoliation syndrome: a disease with an environmental component. Curr Opin Ophthalmol. 2015;26(2):78-81.
5. Ritch R. Ocular and systemic manifestations of exfoliation syndrome. J Glaucoma. 2014;23(8 Suppl 1):S1-8.
6. Pasquale LR, Borras T, Fingert JH, Wiggs JL, Ritch R. Exfoliation syndrome: assembling the puzzle pieces. Acta Ophthalmol. 2016;94(6):e505-12.
7. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081-90.
8. Topouzis F, Wilson MR, Harris A, Anastasopoulos E, Yu F, Mavroudis L, et al. Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study. Am J Ophthalmol. 2007;144(4):511-9.
9. Burr JM, Mowatt G, Hernandez R, Siddiqui MA, Cook J, Lourenco T, et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess. 2007;11(41):iii-iv, ix-x, 1-190.
10. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48-56.
11. Kim JH, Rabiolo A, Morales E, Yu F, Afifi AA, Nouri-Mahdavi K, et al. Risk Factors for Fast Visual Field Progression in Glaucoma. Am J Ophthalmol. 2019;207:268-78.
12. Zhou K, Shang X, Wang XY, Wang XJ, Cheng HH, Hu HS, et al. [Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area]. Zhonghua Yan Ke Za Zhi. 2019;55(10):777-84.
13. Chan TCW, Bala C, Siu A, Wan F, White A. Risk Factors for Rapid Glaucoma Disease Progression. Am J Ophthalmol. 2017;180:151-7.
14. Actis AG, Versino E, Brogliatti B, Rolle T. Risk Factors for Primary Open Angle Glaucoma (POAG) Progression: A Study Ruled in Torino. Open Ophthalmol J. 2016;10:129-39.
15. Hung KH, Cheng CY, Liu CJ. Risk factors for predicting visual field progression in Chinese patients with primary open-angle glaucoma: A retrospective study. J Chin Med Assoc. 2015;78(7):418-23.
16. Gordon P, Flanagan P. Smoking: A risk factor for vascular disease. J Vasc Nurs. 2016;34(3):79-86.
17. Law SM, Lu X, Yu F, Tseng V, Law SK, Coleman AL. Cigarette smoking and glaucoma in the United States population. Eye (Lond). 2018;32(4):716-25.
18. Lee AJ, Rochtchina E, Wang JJ, Healey PR, Mitchell P. Does smoking affect intraocular pressure? Findings from the Blue Mountains Eye Study. J Glaucoma. 2003;12(3):209-12.
19. Lee CS, Owen JP, Yanagihara RT, Lorch A, Pershing S, Hyman L, et al. Smoking Is Associated with Higher Intraocular Pressure Regardless of Glaucoma: A Retrospective Study of 12.5 Million Patients Using the Intelligent Research in Sight (IRIS®) Registry. Ophthalmology Glaucoma. 2020;3(4):253-61.
20. Pérez-de-Arcelus M, Toledo E, Martínez-González M, Martín-Calvo N, Fernández-Montero A, Moreno-Montañés J. Smoking and incidence of glaucoma: The SUN Cohort. Medicine (Baltimore). 2017;96(1):e5761.
21. Wang D, Huang Y, Huang C, Wu P, Lin J, Zheng Y, et al. Association analysis of cigarette smoking with onset of primary open-angle glaucoma and glaucoma-related biometric parameters. BMC Ophthalmol. 2012;12:59.
22. Kang JH, Pasquale LR, Rosner BA, Willett WC, Egan KM, Faberowski N, et al. Prospective study of cigarette smoking and the risk of primary open-angle glaucoma. Arch Ophthalmol. 2003;121(12):1762-8.
23. Chiotoroiu SM, Pop de Popa D, Stefaniu GI, Secureanu FA, Purcarea VL. The importance of alcohol abuse and smoking in the evolution of glaucoma disease. J Med Life. 2013;6(2):226-9.
24. Zanon-Moreno V, Garcia-Medina JJ, Zanon-Viguer V, Moreno-Nadal MA, Pinazo-Duran MD. Smoking, an additional risk factor in elder women with primary open-angle glaucoma. Mol Vis. 2009;15:2953-9.
25. Edwards R, Thornton J, Ajit R, Harrison RA, Kelly SP. Cigarette smoking and primary open angle glaucoma: a systematic review. J Glaucoma. 2008;17(7):558-66.
26. Bonovas S, Filioussi K, Tsantes A, Peponis V. Epidemiological association between cigarette smoking and primary open-angle glaucoma: a meta-analysis. Public Health. 2004;118(4):256-61.
27. Zhou Y, Zhu W, Wang C. The effect of smoking on the risk of primary open-angle glaucoma: an updated meta-analysis of six observational studies. Public Health. 2016;140:84-90.
28. Jain V, Jain M, Abdull MM, Bastawrous A. The association between cigarette smoking and primary open-angle glaucoma: a systematic review. Int Ophthalmol. 2017;37(1):291-301.
29. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7.
30. European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 2: Classification and terminologySupported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology. Br J Ophthalmol. 2017;101(5):73-127.
31. Wall M, Woodward KR, Doyle CK, Artes PH. Repeatability of automated perimetry: a comparison between standard automated perimetry with stimulus size III and V, matrix, and motion perimetry. Invest Ophthalmol Vis Sci. 2009;50(2):974-9.
32. Nguyen AT, Greenfield DS, Bhakta AS, Lee J, Feuer WJ. Detecting Glaucoma Progression Using Guided Progression Analysis with OCT and Visual Field Assessment in Eyes Classified by International Classification of Disease Severity Codes. Ophthalmology Glaucoma. 2019;2(1):36-46.
33. Liebmann K, De Moraes CG, Liebmann JM. Measuring Rates of Visual Field Progression in Linear Versus Nonlinear Scales: Implications for Understanding the Relationship Between Baseline Damage and Target Rates of Glaucoma Progression. J Glaucoma. 2017;26(8):721-5.
34. Salonikiou A, Founti P, Kilintzis V, Antoniadis A, Anastasopoulos E, Pappas T, et al. Tolerable rates of visual field progression in a population-based sample of patients with glaucoma. Br J Ophthalmol. 2018;102(7):916-21.
35. Berchuck SI, Mukherjee S, Medeiros FA. Estimating Rates of Progression and Predicting Future Visual Fields in Glaucoma Using a Deep Variational Autoencoder. Sci Rep. 2019;9(1):18113.
36. Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St. Louis, Mo. ; London: Mosby; 1993.
37. Mehra KS, Roy PN, Khare BB. Tobacco smoking and glaucoma. Ann Ophthalmol. 1976;8(4):462-4.
38. Klaver JH, Greve EL, Goslinga H, Geijssen HC, Heuvelmans JH. Blood and plasma viscosity measurements in patients with glaucoma. Br J Ophthalmol. 1985;69(10):765-70.
39. Rojanapongpun P, Drance SM. The effects of nicotine on the blood flow of the ophthalmic artery and the finger circulation. Graefes Arch Clin Exp Ophthalmol. 1993;231(7):371-4.
40. Ritch R, Prata TS, de Moraes CG, Vessani RM, Costa VP, Konstas AG, et al. Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis. Acta Ophthalmol. 2010;88(1):91-5.
41. Saatci OA, Ferliel ST, Ferliel M, Kaynak S, Ergin MH. Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion. Int Ophthalmol. 1999;23(2):75-8.
42. Kang JH, Wiggs JL, Rosner BA, Haines J, Abdrabou W, Pasquale LR. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with hypertension, alcohol intake, and cigarette smoking. Arch Ophthalmol. 2011;129(6):773-80.
43. Ghaffari Sharaf M, Damji KF, Unsworth LD. Recent advances in risk factors associated with ocular exfoliation syndrome. Acta Ophthalmol. 2020;98(2):113-20.
44. Li X, He J, Sun J. LOXL1 gene polymorphisms are associated with exfoliation syndrome/exfoliation glaucoma risk: An updated meta-analysis. PLoS One. 2021;16(4):e0250772.
45. Eivers SB, Greene AG, Dervan E, O'Brien C, Wallace D. Prevalence of Pseudoexfoliation Glaucoma Risk-associated Variants Within Lysyl Oxidase-like 1 in an Irish Population. J Glaucoma. 2020;29(6):417-22.
46. Wang L, Yu Y, Fu S, Zhao W, Liu P. LOXL1 Gene Polymorphism With Exfoliation Syndrome/Exfoliation Glaucoma: A Meta-Analysis. J Glaucoma. 2016;25(1):62-94.